nektar therapeutics is a leading biopharmaceutical company developing a robust pipeline of novel therapeutics based on its advanced polymer conjugate chemistry technology platform.

Sector

Professional, Scientific, and Technical Services

Industry

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

CEO

Howard Robin

nektar.com/ →

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Alerts

News

Wall Street Brunch: Oil And Rates Will Still Dominate Sentiment

Rosen Law Firm Encourages Hub Group, Inc. Investors to Inquire About Securities Class Action Investigation - HUBG

Gamestop, Carnival, Chewy, Jefferies, and More to Watch This Week

Why Arm Holdings Stock Rallied This Week

Atlas Energy Stock Jumps 39% YTD, but One Fund Cut Exposure by $15 Million Last Quarter

LU Investors Have Opportunity to Lead Lufax Holding Ltd Securities Fraud Lawsuit with the Schall Law Firm

This $7 Million Masimo Exit Came Before a 34% Surge on $9.9 Billion Acquisition

Amazon Gets Its Biggest Hit Movie Ever With ‘Project Hail Mary'

The Best 3 Renewable Energy Stocks to Buy and Hold for Decades

Paramount And Warner Bros. Discovery Combined Will Control 40% Of Acquired TV Viewing On Streaming.

Here's Why High Oil Prices Are Hurting Precious Metals Mining Stocks

IonQ's Revenue Just Tripled to $130 Million. Is This Quantum Stock Finally Worth Buying?

This Investor Exited a $22 Million GRAIL Stake Before a 50% One-Day Stock Crash Last Month

Is Lemonade a Buy After Morgan Stanley's Upgrade?

24 Safer Buys From 10 Years Of Dogcatcher Digging

ROSEN, A LONGSTANDING LAW FIRM, Encourages Concorde International Group Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CIGL

METC IMPORTANT DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Ramaco Resources, Inc. Investors to Secure Counsel Before Important March 31 Deadline in Securities Class Action - METC

Elon Musk unveils chip manufacturing plans for SpaceX and Tesla

Why a Full Exit From Cogent Communications Amid a 74% Stock Drop Could Matter for Investors

The Era of AI Agents Has Arrived. 2 Stocks on Track to Win.

About